===== phenotype 28=================================================================
proportion of pts: 0.199920666402
lambda: 9462.78106893
----------------------------------------
Range name na	0.222
Hypertensive disease	0.214
Disorders of the eye and adnexa	0.199
Disorders of lipoid metabolism	0.196
General symptoms	0.169
----------------------------------------
Fibrinolytic Agents	0.188
Antipyretics	0.172
Cyclooxygenase Inhibitors	0.167
Platelet Aggregation Inhibitors	0.164
Anti-Inflammatory Agents, Non-Steroidal	0.155
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.154
===== phenotype 17=================================================================
proportion of pts: 0.171360571202
lambda: 7026.27791851
----------------------------------------
Other forms of heart disease	0.236
Hypertensive disease	0.233
Range name na	0.212
Disorders of lipoid metabolism	0.177
Symptoms involving respiratory system and other chest symptoms	0.143
----------------------------------------
Anti-Arrhythmia Agents	0.188
Antihypertensive Agents	0.184
Anticoagulants	0.169
Sympatholytics	0.166
Rodenticides	0.153
Vasodilator Agents	0.140
===== phenotype 21=================================================================
proportion of pts: 0.181277270924
lambda: 7000.02191692
----------------------------------------
Disorders of lipoid metabolism	0.264
Diabetes	0.213
Symptoms involving respiratory system and other chest symptoms	0.188
Arthropathies and related disorders	0.180
Rheumatism, excluding the back	0.156
----------------------------------------
Anti-Arrhythmia Agents	0.184
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.168
Anticholesteremic Agents	0.167
Sympatholytics	0.161
Adrenergic beta-1 Receptor Antagonists	0.160
Hypolipidemic Agents	0.160
===== phenotype 36=================================================================
proportion of pts: 0.174137247124
lambda: 6973.67504275
----------------------------------------
Hypertensive disease	0.212
Range name na	0.208
Arthropathies and related disorders	0.200
Dorsopathies	0.196
Rheumatism, excluding the back	0.185
----------------------------------------
Antihypertensive Agents	0.185
Analgesics, Non-Narcotic	0.172
Antipyretics	0.171
Anti-Inflammatory Agents, Non-Steroidal	0.165
Cyclooxygenase Inhibitors	0.160
Angiotensin-Converting Enzyme Inhibitors	0.146
===== phenotype 49=================================================================
proportion of pts: 0.189607298691
lambda: 6841.38534309
----------------------------------------
Range name na	0.188
Arthropathies and related disorders	0.174
Rheumatism, excluding the back	0.170
Hypertensive disease	0.167
Dorsopathies	0.158
General symptoms	0.144
----------------------------------------
Anti-Allergic Agents	0.219
Bronchodilator Agents	0.204
Anti-Inflammatory Agents	0.194
Vitamins	0.192
Bone Density Conservation Agents	0.190
===== phenotype 7=================================================================
proportion of pts: 0.166997223324
lambda: 6049.61276834
----------------------------------------
Hypertensive disease	0.284
Disorders of lipoid metabolism	0.268
Acute respiratory infections	0.225
Symptoms involving respiratory system and other chest symptoms	0.223
----------------------------------------
Fibrinolytic Agents	0.182
Antipyretics	0.173
Cyclooxygenase Inhibitors	0.173
Anti-Inflammatory Agents, Non-Steroidal	0.167
Platelet Aggregation Inhibitors	0.162
Antihypertensive Agents	0.143
===== phenotype 47=================================================================
proportion of pts: 0.180880602935
lambda: 5807.60589939
----------------------------------------
Hypertensive disease	0.197
Symptoms involving respiratory system and other chest symptoms	0.178
Disorders of lipoid metabolism	0.167
Diseases of esophagus, stomach, and duodenum	0.165
Other diseases of the upper respiratory tract	0.151
Acute respiratory infections	0.143
----------------------------------------
Histamine H1 Antagonists, Non-Sedating	0.206
Bronchodilator Agents	0.205
Proton Pump Inhibitors	0.205
Anti-Ulcer Agents	0.198
Anti-Allergic Agents	0.186
===== phenotype 46=================================================================
proportion of pts: 0.173343911146
lambda: 5787.89874447
----------------------------------------
Hypertensive disease	0.221
Rheumatism, excluding the back	0.217
Disorders of lipoid metabolism	0.195
Arthropathies and related disorders	0.193
Dorsopathies	0.174
----------------------------------------
Fibrinolytic Agents	0.235
Platelet Aggregation Inhibitors	0.222
Cyclooxygenase Inhibitors	0.205
Anti-Inflammatory Agents, Non-Steroidal	0.195
Diuretics	0.143
===== phenotype 5=================================================================
proportion of pts: 0.177707259024
lambda: 5731.52797486
----------------------------------------
Nutritional deficiencies	0.224
Diabetes	0.219
General symptoms	0.209
Disorders of lipoid metabolism	0.196
Na	0.152
----------------------------------------
Antihypertensive Agents	0.191
Cyclooxygenase Inhibitors	0.170
Anti-Inflammatory Agents, Non-Steroidal	0.168
Antipyretics	0.167
Vitamins	0.155
Bone Density Conservation Agents	0.149
===== phenotype 9=================================================================
proportion of pts: 0.157477191591
lambda: 5689.63401724
----------------------------------------
Hypertensive disease	0.245
Ischemic heart disease	0.231
Disorders of lipoid metabolism	0.213
Diseases of arteries, arterioles, and capillaries	0.160
Cerebrovascular disease	0.150
----------------------------------------
Antipyretics	0.184
Anticholesteremic Agents	0.177
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.171
Platelet Aggregation Inhibitors	0.167
Cyclooxygenase Inhibitors	0.160
Anti-Inflammatory Agents, Non-Steroidal	0.141
===== phenotype 32=================================================================
proportion of pts: 0.169773899246
lambda: 5670.83276929
----------------------------------------
Hypertensive disease	0.268
Disorders of lipoid metabolism	0.218
General symptoms	0.180
Range name na	0.173
Dorsopathies	0.162
----------------------------------------
Anti-Anxiety Agents	0.200
Muscle Relaxants, Central	0.167
Anticonvulsants	0.164
GABA Modulators	0.163
Antidepressive Agents, Tricyclic	0.155
Hypnotics and Sedatives	0.152
===== phenotype 16=================================================================
proportion of pts: 0.186830622769
lambda: 5596.0791088
----------------------------------------
Hypertensive disease	0.234
Diabetes	0.207
Disorders of lipoid metabolism	0.207
Rheumatism, excluding the back	0.179
Arthropathies and related disorders	0.173
----------------------------------------
Anticholesteremic Agents	0.271
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.260
Antihypertensive Agents	0.251
Antipyretics	0.218
===== phenotype 30=================================================================
proportion of pts: 0.128520428401
lambda: 5160.97871259
----------------------------------------
Hypertensive disease	0.273
Dorsopathies	0.216
Diabetes	0.181
Symptoms involving respiratory system and other chest symptoms	0.173
Disorders of the peripheral nervous system	0.157
----------------------------------------
Analgesics	0.184
Anticonvulsants	0.167
Excitatory Amino Acid Antagonists	0.164
Calcium Channel Blockers	0.163
Antiparkinson Agents	0.162
Antimanic Agents	0.159
===== phenotype 31=================================================================
proportion of pts: 0.151130503768
lambda: 5118.1473258
----------------------------------------
Chronic obstructive pulmonary disease and allied conditions	0.226
Hypertensive disease	0.217
Symptoms involving respiratory system and other chest symptoms	0.201
Disorders of lipoid metabolism	0.200
Arthropathies and related disorders	0.157
----------------------------------------
Bronchodilator Agents	0.175
Tocolytic Agents	0.174
Adrenergic beta-2 Receptor Agonists	0.173
Antihypertensive Agents	0.167
Glucocorticoids	0.157
Anti-Inflammatory Agents	0.154
===== phenotype 18=================================================================
proportion of pts: 0.184053946846
lambda: 5035.74038773
----------------------------------------
General symptoms	0.180
Acute respiratory infections	0.172
Symptoms involving skin and other integumentary tissue	0.169
Symptoms involving respiratory system and other chest symptoms	0.166
Hypertensive disease	0.163
Other diseases of the upper respiratory tract	0.151
----------------------------------------
Antihypertensive Agents	0.229
Anti-Inflammatory Agents	0.214
Anti-Allergic Agents	0.202
Calcium Channel Blockers	0.202
Hypnotics and Sedatives	0.153
===== phenotype 22=================================================================
proportion of pts: 0.19000396668
lambda: 4740.91425802
----------------------------------------
Hypertensive disease	0.233
General symptoms	0.208
Disorders of lipoid metabolism	0.196
Range name na	0.189
Diabetes	0.174
----------------------------------------
Analgesics, Non-Narcotic	0.266
Vasodilator Agents	0.257
Diuretics	0.245
Calcium Channel Blockers	0.231
===== phenotype 38=================================================================
proportion of pts: 0.197937326458
lambda: 4733.33025906
----------------------------------------
Hypertensive disease	0.250
Disorders of lipoid metabolism	0.236
Diabetes	0.182
Ischemic heart disease	0.177
Range name na	0.155
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.284
Vasodilator Agents	0.254
Anti-Inflammatory Agents, Non-Steroidal	0.234
Adrenergic alpha-1 Receptor Antagonists	0.228
===== phenotype 39=================================================================
proportion of pts: 0.163427211424
lambda: 4389.19038661
----------------------------------------
Hypertensive disease	0.186
Ischemic heart disease	0.181
Other forms of heart disease	0.163
Symptoms involving respiratory system and other chest symptoms	0.161
Disorders of lipoid metabolism	0.157
Range name na	0.153
----------------------------------------
Vasodilator Agents	0.271
Diuretics	0.260
Vitamins	0.236
Adrenergic beta-Antagonists	0.233
===== phenotype 15=================================================================
proportion of pts: 0.154700515668
lambda: 4331.30348995
----------------------------------------
Hypertensive disease	0.209
Disorders of lipoid metabolism	0.172
Diseases of esophagus, stomach, and duodenum	0.168
Other diseases of intestines and peritoneum	0.154
Other symptoms involving abdomen and pelvis	0.149
Ischemic heart disease	0.148
----------------------------------------
Anti-Ulcer Agents	0.251
Proton Pump Inhibitors	0.241
Analgesics, Opioid	0.190
Hypnotics and Sedatives	0.176
Adjuvants, Anesthesia	0.142
===== phenotype 19=================================================================
proportion of pts: 0.17572391908
lambda: 4330.04332398
----------------------------------------
Arthropathies and related disorders	0.213
Hypertensive disease	0.209
Range name na	0.204
Rheumatism, excluding the back	0.193
Disorders of lipoid metabolism	0.181
----------------------------------------
Proton Pump Inhibitors	0.301
Anti-Ulcer Agents	0.285
Diuretics	0.214
Anti-Allergic Agents	0.201
===== phenotype 1=================================================================
proportion of pts: 0.163823879413
lambda: 4304.02527471
----------------------------------------
Hypertensive disease	0.262
Disorders of lipoid metabolism	0.228
Na	0.176
Symptoms involving respiratory system and other chest symptoms	0.170
Organic sleep disorders	0.164
----------------------------------------
Serotonin Uptake Inhibitors	0.282
Antidepressive Agents, Second-Generation	0.209
Dermatologic Agents	0.185
Anti-Allergic Agents	0.165
Anti-Inflammatory Agents	0.160
===== phenotype 0=================================================================
proportion of pts: 0.168187227291
lambda: 4125.49658378
----------------------------------------
Hypertensive disease	0.287
Range name na	0.270
General symptoms	0.241
Symptoms involving respiratory system and other chest symptoms	0.202
----------------------------------------
Anti-Bacterial Agents	0.223
Histamine H1 Antagonists	0.218
Antipruritics	0.212
Anti-Ulcer Agents	0.186
Antidepressive Agents, Second-Generation	0.161
===== phenotype 23=================================================================
proportion of pts: 0.146767155891
lambda: 3961.11972987
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.229
Other symptoms involving abdomen and pelvis	0.209
Symptoms involving skin and other integumentary tissue	0.196
Arthropathies and related disorders	0.190
Other diseases of respiratory system	0.176
----------------------------------------
Antipyretics	0.221
Antihypertensive Agents	0.207
Anti-Inflammatory Agents, Non-Steroidal	0.207
Cyclooxygenase Inhibitors	0.201
Diuretics	0.164
===== phenotype 8=================================================================
proportion of pts: 0.160650535502
lambda: 3946.90094592
----------------------------------------
Diabetes	0.244
Hypertensive disease	0.227
General symptoms	0.189
Range name na	0.184
Symptoms involving respiratory system and other chest symptoms	0.156
----------------------------------------
Hypoglycemic Agents	0.272
Platelet Aggregation Inhibitors	0.217
Topoisomerase II Inhibitors	0.175
Glucocorticoids	0.169
Tocolytic Agents	0.167
===== phenotype 12=================================================================
proportion of pts: 0.126537088457
lambda: 3924.94336514
----------------------------------------
Hypertensive disease	0.270
Range name na	0.202
Disorders of lipoid metabolism	0.201
Arthropathies and related disorders	0.184
General symptoms	0.143
----------------------------------------
Enzyme Inhibitors	0.263
Immunosuppressive Agents	0.262
Antirheumatic Agents	0.248
Antimetabolites, Antineoplastic	0.226
===== phenotype 35=================================================================
proportion of pts: 0.16144387148
lambda: 3892.79170812
----------------------------------------
Other diseases of urinary system	0.275
Other forms of heart disease	0.259
Disorders of the eye and adnexa	0.257
Disorders of thyroid gland	0.209
----------------------------------------
Antihypertensive Agents	0.209
Anti-Arrhythmia Agents	0.166
Anti-Inflammatory Agents, Non-Steroidal	0.165
Cyclooxygenase Inhibitors	0.159
Diuretics	0.157
Platelet Aggregation Inhibitors	0.144
===== phenotype 6=================================================================
proportion of pts: 0.149147163824
lambda: 3862.91171368
----------------------------------------
Hypertensive disease	0.318
Range name na	0.274
General symptoms	0.224
Symptoms involving respiratory system and other chest symptoms	0.184
----------------------------------------
Anti-Arrhythmia Agents	0.235
Adrenergic beta-1 Receptor Antagonists	0.209
Sympatholytics	0.200
Antihypertensive Agents	0.191
Dermatologic Agents	0.165
===== phenotype 45=================================================================
proportion of pts: 0.159857199524
lambda: 3723.94737995
----------------------------------------
Range name na	0.249
Hypertensive disease	0.242
Disorders of lipoid metabolism	0.176
Arthropathies and related disorders	0.168
Rheumatism, excluding the back	0.164
----------------------------------------
Glucocorticoids	0.289
Anti-Inflammatory Agents	0.264
Antiemetics	0.227
Antineoplastic Agents, Hormonal	0.220
===== phenotype 13=================================================================
proportion of pts: 0.174930583102
lambda: 3559.45995801
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.227
Ischemic heart disease	0.217
Other forms of heart disease	0.203
Range name na	0.193
Anemias	0.160
----------------------------------------
Platelet Aggregation Inhibitors	0.344
Cyclooxygenase Inhibitors	0.340
Anti-Inflammatory Agents, Non-Steroidal	0.316
===== phenotype 14=================================================================
proportion of pts: 0.16501388338
lambda: 3339.92719312
----------------------------------------
Hypertensive disease	0.262
Disorders of lipoid metabolism	0.209
Range name na	0.196
Diabetes	0.177
Arthropathies and related disorders	0.157
----------------------------------------
Sodium Potassium Chloride Symporter Inhibitors	0.304
Angiotensin II Type 1 Receptor Blockers	0.246
Gout Suppressants	0.231
Tubulin Modulators	0.219
===== phenotype 10=================================================================
proportion of pts: 0.155493851646
lambda: 3161.71306691
----------------------------------------
Hypertensive disease	0.312
Disorders of lipoid metabolism	0.253
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.222
Nephritis, nephrotic syndrome, and nephrosis	0.213
----------------------------------------
Bone Density Conservation Agents	0.236
Vitamins	0.225
Angiotensin-Converting Enzyme Inhibitors	0.185
Diuretics	0.184
Calcium Channel Blockers	0.170
===== phenotype 25=================================================================
proportion of pts: 0.154700515668
lambda: 3132.70827286
----------------------------------------
Other diseases of urinary system	0.217
Range name na	0.216
Symptoms involving respiratory system and other chest symptoms	0.207
Other forms of heart disease	0.188
Symptoms involving urinary system	0.171
----------------------------------------
Anti-Bacterial Agents	0.287
Bone Density Conservation Agents	0.261
Vitamins	0.241
Topoisomerase II Inhibitors	0.211
===== phenotype 40=================================================================
proportion of pts: 0.176913923046
lambda: 3049.15065737
----------------------------------------
Diabetes	0.278
Disorders of lipoid metabolism	0.259
Hypertensive disease	0.238
Disorders of the eye and adnexa	0.224
----------------------------------------
Anti-Allergic Agents	0.350
Anti-Inflammatory Agents	0.347
Bronchodilator Agents	0.303
===== phenotype 29=================================================================
proportion of pts: 0.139230464102
lambda: 3022.28656175
----------------------------------------
Arthropathies and related disorders	0.287
Range name na	0.269
Rheumatism, excluding the back	0.226
Disorders of the eye and adnexa	0.219
----------------------------------------
Analgesics	0.270
Calcium Channel Blockers	0.253
Anti-Anxiety Agents	0.243
Anticonvulsants	0.234
===== phenotype 3=================================================================
proportion of pts: 0.12534708449
lambda: 2758.50250614
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.299
Other forms of heart disease	0.267
Range name na	0.246
Anemias	0.188
----------------------------------------
Anti-Anxiety Agents	0.223
Hypnotics and Sedatives	0.220
Antiemetics	0.202
GABA Modulators	0.180
Anticonvulsants	0.175
===== phenotype 11=================================================================
proportion of pts: 0.113050376835
lambda: 2041.30653225
----------------------------------------
Other forms of heart disease	0.243
Symptoms involving respiratory system and other chest symptoms	0.239
Other diseases of respiratory system	0.189
Ischemic heart disease	0.185
Miscellaneous diagnostic and therapeutic procedures	0.144
----------------------------------------
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.383
Anticholesteremic Agents	0.372
Anesthetics, Local	0.245
===== phenotype 4=================================================================
proportion of pts: 0.140817136057
lambda: 1919.44459486
----------------------------------------
Arthropathies and related disorders	0.286
Rheumatism, excluding the back	0.269
Disorders of lipoid metabolism	0.245
Symptoms involving head and neck	0.200
----------------------------------------
Vasodilator Agents	0.374
Calcium Channel Blockers	0.341
Anticonvulsants	0.285
===== phenotype 33=================================================================
proportion of pts: 0.158667195557
lambda: 1754.05995586
----------------------------------------
Hypertensive disease	0.257
Disorders of lipoid metabolism	0.212
Nonspecific findings on examination of blood	0.198
Rheumatism, excluding the back	0.182
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.150
----------------------------------------
Antihypertensive Agents	0.547
Calcium Channel Blockers	0.453
===== phenotype 27=================================================================
proportion of pts: 0.127727092424
lambda: 1345.32062675
----------------------------------------
Hypertensive disease	0.251
Rheumatism, excluding the back	0.204
Organic sleep disorders	0.187
Symptoms involving digestive system	0.179
Dorsopathies	0.179
----------------------------------------
Anti-Anxiety Agents	0.502
Hypnotics and Sedatives	0.498
===== phenotype 37=================================================================
proportion of pts: 0.152320507735
lambda: 1098.38946831
----------------------------------------
Arthropathies and related disorders	0.230
Dorsopathies	0.211
Rheumatism, excluding the back	0.204
Range name na	0.191
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.164
----------------------------------------
Anti-Arrhythmia Agents	1.000
===== phenotype 24=================================================================
proportion of pts: 0.142800476002
lambda: 880.349823484
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.252
Hypertensive disease	0.215
General symptoms	0.192
Range name na	0.172
Symptoms involving urinary system	0.169
----------------------------------------
Anti-Ulcer Agents	1.000
===== phenotype 42=================================================================
proportion of pts: 0.120983736612
lambda: 797.98490077
----------------------------------------
Hypertensive disease	0.347
Range name na	0.268
Diabetes	0.195
General symptoms	0.189
----------------------------------------
Antioxidants	1.000
===== phenotype 41=================================================================
proportion of pts: 0.12177707259
lambda: 765.152373733
----------------------------------------
Diabetes	0.234
Anemias	0.216
Disorders of the eye and adnexa	0.206
Range name na	0.174
Disorders of lipoid metabolism	0.170
----------------------------------------
Anti-Ulcer Agents	1.000
===== phenotype 34=================================================================
proportion of pts: 0.148353827846
lambda: 647.986219983
----------------------------------------
Other diseases of intestines and peritoneum	0.323
Organic sleep disorders	0.307
Symptoms involving head and neck	0.208
Benign neoplasm of other parts of digestive system	0.162
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 48=================================================================
proportion of pts: 0.117810392701
lambda: 537.720636086
----------------------------------------
Certain traumatic complications and unspecified injuries	0.290
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.260
Fractures	0.231
Hypertensive disease	0.219
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 44=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 43=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 26=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 20=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 2=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
